TITLE

Flu strains selected

AUTHOR(S)
Kondro, Wayne
PUB. DATE
September 2011
SOURCE
CMAJ: Canadian Medical Association Journal;9/6/2011, Vol. 183 Issue 12, pE790
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the approval by the U.S. Food and Drug Administration of a flu vaccine formulation for 2011-2012 that aimed to reduce the effects of three flu virus strains.
ACCESSION #
65927760

 

Related Articles

  • Monovalent influenza A (H1N1) vaccine licensure expanded to include children, 6 months and older.  // Infectious Disease News;Dec2009, Vol. 22 Issue 12, p17 

    The article reports that the U.S. Food and Drug Administration has expanded the approved use of the inactivated, monovalent H1N1 vaccine from CSL Biotherapies to include children aged 6 months and older, in December 2009.

  • Flu vaccine advice from FDA.  // Pharmacy Today;Feb2013, Vol. 19 Issue 2, p3 

    The article focuses on the advice from the U.S. Food and Drug Administration (FDA) that the information on the availability of influenza vaccine and the level of flu activity can be found at www.flu.gov.

  • Flu vaccine will target both seasonal and H1N1 strains. Berklan, James M. // McKnight's Long-Term Care News;Sep2010, Vol. 31 Issue 9, p6 

    The article reports on new influenza vaccine approved by the U.S. Food and Drug Administration that protects against the H1N1 2009 pandemic virus, as well as two seasonal strains of the flu.

  • High-dose flu vaccine OK'd. Berger, Liza // McKnight's Long-Term Care News;Feb2010, Vol. 31 Issue 2, p3 

    The article reports on the approval of the U.S. Food & Drug Administration to the seasonal influenza vaccine for people 65 years old and older that use a higher dose to produce a stronger response.

  • FDA panel debates adding a fourth strain to influenza vaccine. Levine, Greg // American Journal of Health-System Pharmacy;4/1/2009, Vol. 66 Issue 7, p609 

    The article reports on the Food and Drug Administration (FDA) panel discussion on whether to add a second B strain to influenza vaccines. It says that the pharmaceutical manufacturers in the U.S. are having a hard time predicting which influenza strains are going to infect people in North...

  • Influenza Viral Infections-Part 2. Pellman, Harry // Pediatrics for Parents;2002, Vol. 20 Issue 4, p4 

    Presents information on the influenza vaccines approved by the U.S. Food Administration Drug. Benefits of the vaccine approved for influenza; Effects of the vaccine on the children; Problems faced by vaccines approved; Availability of medication to treat influenza.

  • FDA approves vaccines for 2011-2012 influenza season.  // Infectious Diseases in Children;Aug2011, Vol. 24 Issue 8, p29 

    The article reports on the approval by the U.S. Food and Drug Administration (FDA) of the influenza vaccine formulation for the 2011-2012 season.

  • The 2010-2011 influenza vaccine and related matters. Eickhoff, Theodore C. // Infectious Disease News;Mar2010, Vol. 23 Issue 3, p3 

    The author comments on the determination of the composition of influenza vaccine by the U.S. Food and Drug Administration (FDA) in 2010.

  • FDA approves vaccines for 2012-2013 influenza season.  // Infectious Disease News;Sep2012, Vol. 25 Issue 9, p31 

    The article announces that the U.S. Food and Drug Administration (FDA) has approved the 2012-2013 influenza vaccine formulation for use in the U.S.

  • FDA approves four-strain seasonal influenza vaccine.  // Infectious Diseases in Children;Jan2013, Vol. 26 Issue 1, p5 

    The article announces that the U.S. Food and Drug Administration (FDA) approved Fluarix Quadrivalent, an influenza vaccine from Glaxo-SmithKline for adults and children three years old and above to prevent infection from the influenza virus.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics